Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$33.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Rapid Micro Biosystems,… |
| PDBUY◆ |
| 1.5M |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Apr 30 | HTFL | Heartflow, Inc. | SSELL | 56,224 | $30.05 | $1.7M | -0.7% | Open the original filing on SEC.gov |
| Apr 30 | HTFL | Heartflow, Inc. | SSELL | 892,533 | $29.18 | $26M | -9.5% | Open the original filing on SEC.gov |
| Apr 29 | HTFL | Heartflow, Inc. | SSELL | 797,133 | $29.37 | $23.4M | -7.8% | Open the original filing on SEC.gov |
| Apr 28 | HTFL | Heartflow, Inc. | SSELL | 254,110 | $30.51 | $7.8M | -2.4% | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV◆ | 4.1M | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV◆ | 16.9M | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | PBUY | 1.6M | $16.00 | $25M | +7.4% | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV | 4.1M | — | — | +24.6% | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV | 16.9M | — | — | — | Open the original filing on SEC.gov |